Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 50 entries
Sorted by: Best Match Show Resources per page
Multimodality imaging of anomalous pulmonary veins.

Cardiovascular ultrasound

Nepomuceno R, Zeglinski M, Lerner J, Czarnecki W, Kirkpatrick ID, Strzelczyk J, Jassal DS.
PMID: 21288339
Cardiovasc Ultrasound. 2011 Feb 02;9:3. doi: 10.1186/1476-7120-9-3.

Partial anomalous pulmonary venous connection (PAPVC) is an extremely rare congenital condition where one or more of the pulmonary veins are connected to the venous circulation. Although initially suspected with unexplained right ventricular enlargement on transthoracic echocardiography (TTE), cardiac...

Cite
Nepomuceno R, Zeglinski M, Lerner J, et al. Multimodality imaging of anomalous pulmonary veins. Cardiovasc Ultrasound. 2011;9:3doi: 10.1186/1476-7120-9-3.
Nepomuceno, R., Zeglinski, M., Lerner, J., Czarnecki, W., Kirkpatrick, I. D., Strzelczyk, J., & Jassal, D. S. (2011). Multimodality imaging of anomalous pulmonary veins. Cardiovascular ultrasound, 93. https://doi.org/10.1186/1476-7120-9-3
Nepomuceno, Roman, et al. "Multimodality imaging of anomalous pulmonary veins." Cardiovascular ultrasound vol. 9 (2011): 3. doi: https://doi.org/10.1186/1476-7120-9-3
Nepomuceno R, Zeglinski M, Lerner J, Czarnecki W, Kirkpatrick ID, Strzelczyk J, Jassal DS. Multimodality imaging of anomalous pulmonary veins. Cardiovasc Ultrasound. 2011 Feb 02;9:3. doi: 10.1186/1476-7120-9-3. PMID: 21288339; PMCID: PMC3038141.
Copy Download .nbib Format: NLM
Polysaccharide formulation for improvement of racemic vitamin E bioavailability.

Acta poloniae pharmaceutica

Zimmer Ł, Czarnecki W.
PMID: 17665867
Acta Pol Pharm. 2007 Mar-Apr;64(2):169-74.

The relative bioavailability of polysaccharide--racemic vitamin E preparation in comparison with a commercial product was assessed in a kinetic study of plasma alpha-tocopherol in rabbits. Six male rabbits were used in a cross-over design. Alpha-Tocopherol levels were determined by...

Cite
Zimmer Ł, Czarnecki W. Polysaccharide formulation for improvement of racemic vitamin E bioavailability. Acta Pol Pharm. 2007;64(2):169-74
Zimmer, �. �., & Czarnecki, W. (2007). Polysaccharide formulation for improvement of racemic vitamin E bioavailability. Acta poloniae pharmaceutica, 64(2), 169-74.
Zimmer, Łukasz, and Czarnecki, Wiktor. "Polysaccharide formulation for improvement of racemic vitamin E bioavailability." Acta poloniae pharmaceutica vol. 64,2 (2007): 169-74.
Zimmer Ł, Czarnecki W. Polysaccharide formulation for improvement of racemic vitamin E bioavailability. Acta Pol Pharm. 2007 Mar-Apr;64(2):169-74. PMID: 17665867.
Copy Download .nbib Format: NLM
Substructural Connectivity Fingerprint and Extreme Entropy Machines-A New Method of Compound Representation and Analysis.

Molecules (Basel, Switzerland)

Rataj K, Czarnecki W, Podlewska S, Pocha A, Bojarski AJ.
PMID: 29789513
Molecules. 2018 May 23;23(6). doi: 10.3390/molecules23061242.

Key-based substructural fingerprints are an important element of computer-aided drug design techniques. The usefulness of the fingerprints in filtering compound databases is invaluable, as they allow for the quick rejection of molecules with a low probability of being active....

Cite
Rataj K, Czarnecki W, Podlewska S, et al. Substructural Connectivity Fingerprint and Extreme Entropy Machines-A New Method of Compound Representation and Analysis. Molecules. 2018;23(6)doi: 10.3390/molecules23061242.
Rataj, K., Czarnecki, W., Podlewska, S., Pocha, A., & Bojarski, A. J. (2018). Substructural Connectivity Fingerprint and Extreme Entropy Machines-A New Method of Compound Representation and Analysis. Molecules (Basel, Switzerland), 23(6), . https://doi.org/10.3390/molecules23061242
Rataj, Krzysztof, et al. "Substructural Connectivity Fingerprint and Extreme Entropy Machines-A New Method of Compound Representation and Analysis." Molecules (Basel, Switzerland) vol. 23,6 (2018). doi: https://doi.org/10.3390/molecules23061242
Rataj K, Czarnecki W, Podlewska S, Pocha A, Bojarski AJ. Substructural Connectivity Fingerprint and Extreme Entropy Machines-A New Method of Compound Representation and Analysis. Molecules. 2018 May 23;23(6). doi: 10.3390/molecules23061242. PMID: 29789513; PMCID: PMC6100401.
Copy Download .nbib Format: NLM
[Separation of vitamins in injection "Polybe" and baker's yeast by the method of ion exchange column chromatography].

Acta poloniae pharmaceutica

Nerlo H, Pawlak S, Czarnecki W.
PMID: 4239884
Acta Pol Pharm. 1969;26(2):173-6.

No abstract available.

Cite
Nerlo H, Pawlak S, Czarnecki W. Rozdział witamin w iniekcji "Polybe" i drozdzach piekarskich metoda chromatografii kolumnowej jonowymiennej. [Separation of vitamins in injection "Polybe" and baker's yeast by the method of ion exchange column chromatography]. Acta Pol Pharm. 1969;26(2):173-6
Nerlo, H., Pawlak, S., & Czarnecki, W. (1969). Rozdział witamin w iniekcji "Polybe" i drozdzach piekarskich metoda chromatografii kolumnowej jonowymiennej. [Separation of vitamins in injection "Polybe" and baker's yeast by the method of ion exchange column chromatography]. Acta poloniae pharmaceutica, 26(2), 173-6.
Nerlo, H, et al. "Rozdział witamin w iniekcji "Polybe" i drozdzach piekarskich metoda chromatografii kolumnowej jonowymiennej." [Separation of vitamins in injection "Polybe" and baker's yeast by the method of ion exchange column chromatography]. Acta poloniae pharmaceutica vol. 26,2 (1969): 173-6.
Nerlo H, Pawlak S, Czarnecki W. Rozdział witamin w iniekcji "Polybe" i drozdzach piekarskich metoda chromatografii kolumnowej jonowymiennej. [Separation of vitamins in injection "Polybe" and baker's yeast by the method of ion exchange column chromatography]. Acta Pol Pharm. 1969;26(2):173-6. Polish. PMID: 4239884.
Copy Download .nbib Format: NLM
[Identification and determination of vitamin E in germs, grains and bran of wheat].

Acta poloniae pharmaceutica

Nerlo H, Czarnecki W, Polowianiuk E.
PMID: 5673871
Acta Pol Pharm. 1968;25(1):63-7.

No abstract available.

Cite
Nerlo H, Czarnecki W, Polowianiuk E. Identyfikacja i oznaczanie witaminy e w kiełkach, ziarnie i otrebach pszenicy. [Identification and determination of vitamin E in germs, grains and bran of wheat]. Acta Pol Pharm. 1968;25(1):63-7
Nerlo, H., Czarnecki, W., & Polowianiuk, E. (1968). Identyfikacja i oznaczanie witaminy e w kiełkach, ziarnie i otrebach pszenicy. [Identification and determination of vitamin E in germs, grains and bran of wheat]. Acta poloniae pharmaceutica, 25(1), 63-7.
Nerlo, H, et al. "Identyfikacja i oznaczanie witaminy e w kiełkach, ziarnie i otrebach pszenicy." [Identification and determination of vitamin E in germs, grains and bran of wheat]. Acta poloniae pharmaceutica vol. 25,1 (1968): 63-7.
Nerlo H, Czarnecki W, Polowianiuk E. Identyfikacja i oznaczanie witaminy e w kiełkach, ziarnie i otrebach pszenicy. [Identification and determination of vitamin E in germs, grains and bran of wheat]. Acta Pol Pharm. 1968;25(1):63-7. Polish. PMID: 5673871.
Copy Download .nbib Format: NLM
[Differentiation of QSvl-3 complexes in myocardial infarct and chronic cor pulmonale].

Polskie Archiwum Medycyny Wewnetrznej

Dabrowska B, Czarnecki W.
PMID: 1257112
Pol Arch Med Wewn. 1976;55(3):223-7.

No abstract available.

Cite
Dabrowska B, Czarnecki W. Róznicowanie zespołów QSv1-3 w zawale serca i w zespole przewlekłego serca płucnego [Differentiation of QSvl-3 complexes in myocardial infarct and chronic cor pulmonale]. Pol Arch Med Wewn. 1976;55(3):223-7
Dabrowska, B., & Czarnecki, W. (1976). Róznicowanie zespołów QSv1-3 w zawale serca i w zespole przewlekłego serca płucnego [Differentiation of QSvl-3 complexes in myocardial infarct and chronic cor pulmonale]. Polskie Archiwum Medycyny Wewnetrznej, 55(3), 223-7.
Dabrowska, B, and Czarnecki, W. "Róznicowanie zespołów QSv1-3 w zawale serca i w zespole przewlekłego serca płucnego" [Differentiation of QSvl-3 complexes in myocardial infarct and chronic cor pulmonale]. Polskie Archiwum Medycyny Wewnetrznej vol. 55,3 (1976): 223-7.
Dabrowska B, Czarnecki W. Róznicowanie zespołów QSv1-3 w zawale serca i w zespole przewlekłego serca płucnego [Differentiation of QSvl-3 complexes in myocardial infarct and chronic cor pulmonale]. Pol Arch Med Wewn. 1976;55(3):223-7. Polish. PMID: 1257112.
Copy Download .nbib Format: NLM
[Solubilizers of erythromycin A cyclic carbonate L-aspartate].

Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina

Nerlo H, Czarnecki W, Wiktorowicz M, Rudzki Z.
PMID: 7349059
Ann Univ Mariae Curie Sklodowska Med. 1980;35:129-34.

No abstract available.

Cite
Nerlo H, Czarnecki W, Wiktorowicz M, et al. Solubilizatory asparaginianu cyklicznego weglanu erytromycyny. [Solubilizers of erythromycin A cyclic carbonate L-aspartate]. Ann Univ Mariae Curie Sklodowska Med. 1980;35:129-34
Nerlo, H., Czarnecki, W., Wiktorowicz, M., & Rudzki, Z. (1980). Solubilizatory asparaginianu cyklicznego weglanu erytromycyny. [Solubilizers of erythromycin A cyclic carbonate L-aspartate]. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 35129-34.
Nerlo, H, et al. "Solubilizatory asparaginianu cyklicznego weglanu erytromycyny." [Solubilizers of erythromycin A cyclic carbonate L-aspartate]. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina vol. 35 (1980): 129-34.
Nerlo H, Czarnecki W, Wiktorowicz M, Rudzki Z. Solubilizatory asparaginianu cyklicznego weglanu erytromycyny. [Solubilizers of erythromycin A cyclic carbonate L-aspartate]. Ann Univ Mariae Curie Sklodowska Med. 1980;35:129-34. Polish. PMID: 7349059.
Copy Download .nbib Format: NLM
Haemodynamic effects of inosine. A new drug for failing human heart?.

Pharmacological research

Czarnecki W, Czarnecki A.
PMID: 2594615
Pharmacol Res. 1989 Sep-Oct;21(5):587-94. doi: 10.1016/1043-6618(89)90200-4.

Haemodynamic effects of inosine were studied in intact dogs and subsequently in patients suffering from prolonged otherwise intractable cardiogenic shock. The nucleoside significantly improve myocardial performance in patients with an extremely low cardiac index by 63 +/- 29% as...

Cite
Czarnecki W, Czarnecki A. Haemodynamic effects of inosine. A new drug for failing human heart?. Pharmacol Res. 1989;21(5):587-94doi: 10.1016/1043-6618(89)90200-4.
Czarnecki, W., & Czarnecki, A. (1989). Haemodynamic effects of inosine. A new drug for failing human heart?. Pharmacological research, 21(5), 587-94. https://doi.org/10.1016/1043-6618(89)90200-4
Czarnecki, W, and Czarnecki, A. "Haemodynamic effects of inosine. A new drug for failing human heart?." Pharmacological research vol. 21,5 (1989): 587-94. doi: https://doi.org/10.1016/1043-6618(89)90200-4
Czarnecki W, Czarnecki A. Haemodynamic effects of inosine. A new drug for failing human heart?. Pharmacol Res. 1989 Sep-Oct;21(5):587-94. doi: 10.1016/1043-6618(89)90200-4. PMID: 2594615.
Copy Download .nbib Format: NLM
Metabolic and haemodynamic responses to adrenaline in normal dogs.

Basic research in cardiology

Drake AJ, Herbaczynska-Cedro K, Ceremuzynski L, Czarnecki W, Noble MI.
PMID: 7092777
Basic Res Cardiol. 1982 Mar-Apr;77(2):188-96. doi: 10.1007/BF01908172.

The metabolic and haemodynamic effects of adrenaline were investigated in 6 intact anaesthetized dogs, which were subjected to an infusion of adrenaline. The dose given was similar to the endogenous production rate of adrenaline in experimental myocardial infarction. Adrenaline...

Cite
Drake AJ, Herbaczynska-Cedro K, Ceremuzynski L, et al. Metabolic and haemodynamic responses to adrenaline in normal dogs. Basic Res Cardiol. 1982;77(2):188-96doi: 10.1007/BF01908172.
Drake, A. J., Herbaczynska-Cedro, K., Ceremuzynski, L., Czarnecki, W., & Noble, M. I. (1982). Metabolic and haemodynamic responses to adrenaline in normal dogs. Basic research in cardiology, 77(2), 188-96. https://doi.org/10.1007/BF01908172
Drake, A J, et al. "Metabolic and haemodynamic responses to adrenaline in normal dogs." Basic research in cardiology vol. 77,2 (1982): 188-96. doi: https://doi.org/10.1007/BF01908172
Drake AJ, Herbaczynska-Cedro K, Ceremuzynski L, Czarnecki W, Noble MI. Metabolic and haemodynamic responses to adrenaline in normal dogs. Basic Res Cardiol. 1982 Mar-Apr;77(2):188-96. doi: 10.1007/BF01908172. PMID: 7092777.
Copy Download .nbib Format: NLM
Toward the border between neural and Markovian paradigms.

IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society

Wilinski P, Solaiman B, Hillion A, Czarnecki W.
PMID: 18255933
IEEE Trans Syst Man Cybern B Cybern. 1998;28(2):146-59. doi: 10.1109/3477.662756.

A new tendency in the design of modern signal processing methods is the creation of hybrid algorithms. This paper gives an overview of different signal processing algorithms situated halfway between Markovian and neural paradigms. A new systematic way to...

Cite
Wilinski P, Solaiman B, Hillion A, et al. Toward the border between neural and Markovian paradigms. IEEE Trans Syst Man Cybern B Cybern. 1998;28(2):146-59doi: 10.1109/3477.662756.
Wilinski, P., Solaiman, B., Hillion, A., & Czarnecki, W. (1998). Toward the border between neural and Markovian paradigms. IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society, 28(2), 146-59. https://doi.org/10.1109/3477.662756
Wilinski, P, et al. "Toward the border between neural and Markovian paradigms." IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society vol. 28,2 (1998): 146-59. doi: https://doi.org/10.1109/3477.662756
Wilinski P, Solaiman B, Hillion A, Czarnecki W. Toward the border between neural and Markovian paradigms. IEEE Trans Syst Man Cybern B Cybern. 1998;28(2):146-59. doi: 10.1109/3477.662756. PMID: 18255933.
Copy Download .nbib Format: NLM
ST 567 compared with propranolol in stable angina.

European heart journal

Ceremuzynski L, Nartowicz E, Dluzniewski M, Perkowicz J, Czarnecki W, Burduk P, Budaj A, Bednarz B, Chamiec T, Jurgiel R.
PMID: 3330528
Eur Heart J. 1987 Dec;8:159-63. doi: 10.1093/eurheartj/8.suppl_l.159.

UNLABELLED: The aim of this study was to investigate the effectiveness of ST 567 in patients suffering from ischaemic heart disease and to compare the effects of this drug with those of propranolol. The study group consisted of 48...

Cite
Ceremuzynski L, Nartowicz E, Dluzniewski M, et al. ST 567 compared with propranolol in stable angina. Eur Heart J. 1987;8:159-63doi: 10.1093/eurheartj/8.suppl_l.159.
Ceremuzynski, L., Nartowicz, E., Dluzniewski, M., Perkowicz, J., Czarnecki, W., Burduk, P., Budaj, A., Bednarz, B., Chamiec, T., & Jurgiel, R. (1987). ST 567 compared with propranolol in stable angina. European heart journal, 8159-63. https://doi.org/10.1093/eurheartj/8.suppl_l.159
Ceremuzynski, L, et al. "ST 567 compared with propranolol in stable angina." European heart journal vol. 8 (1987): 159-63. doi: https://doi.org/10.1093/eurheartj/8.suppl_l.159
Ceremuzynski L, Nartowicz E, Dluzniewski M, Perkowicz J, Czarnecki W, Burduk P, Budaj A, Bednarz B, Chamiec T, Jurgiel R. ST 567 compared with propranolol in stable angina. Eur Heart J. 1987 Dec;8:159-63. doi: 10.1093/eurheartj/8.suppl_l.159. PMID: 3330528.
Copy Download .nbib Format: NLM
[LMOP-2: a new Polish device using a ND+3-YAG laser for transscleral coagulation of the retina and ciliary body].

Klinika oczna

Kecik T, Jankiewicz Z, Czarnecki W, Nowakowski W.
PMID: 3795843
Klin Oczna. 1986 Jun;88(6):218-9.

No abstract available.

Cite
Kecik T, Jankiewicz Z, Czarnecki W, et al. LMOP-2--nowe, polskie urzqdzenie z laserem Nd+3-YAG do poprzeztwardówkowej koagulacji siatkówki i ciała rzeskowego. [LMOP-2: a new Polish device using a ND+3-YAG laser for transscleral coagulation of the retina and ciliary body]. Klin Oczna. 1986;88(6):218-9
Kecik, T., Jankiewicz, Z., Czarnecki, W., & Nowakowski, W. (1986). LMOP-2--nowe, polskie urzqdzenie z laserem Nd+3-YAG do poprzeztwardówkowej koagulacji siatkówki i ciała rzeskowego. [LMOP-2: a new Polish device using a ND+3-YAG laser for transscleral coagulation of the retina and ciliary body]. Klinika oczna, 88(6), 218-9.
Kecik, T, et al. "LMOP-2--nowe, polskie urzqdzenie z laserem Nd+3-YAG do poprzeztwardówkowej koagulacji siatkówki i ciała rzeskowego." [LMOP-2: a new Polish device using a ND+3-YAG laser for transscleral coagulation of the retina and ciliary body]. Klinika oczna vol. 88,6 (1986): 218-9.
Kecik T, Jankiewicz Z, Czarnecki W, Nowakowski W. LMOP-2--nowe, polskie urzqdzenie z laserem Nd+3-YAG do poprzeztwardówkowej koagulacji siatkówki i ciała rzeskowego. [LMOP-2: a new Polish device using a ND+3-YAG laser for transscleral coagulation of the retina and ciliary body]. Klin Oczna. 1986 Jun;88(6):218-9. Polish. PMID: 3795843.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 50 entries